published patent: ORAL DNA COMPOSITION FOR HEPATITIS B VIRUS CHRONIC INFECTION

TitleORAL DNA COMPOSITION FOR HEPATITIS B VIRUS CHRONIC INFECTION
Priority Date2002-02-28 US 10/359945P
Inventors
Issue Date2003
Citation
WO Published patent application WO 03072012. World Intellectual Property Organization (WIPO), PatentScope, 2003 How to Cite?
AbstractThe present invention provides an oral DNA composition for improving an impaired immunity associated with chronic infection of hepatitis B virus HBV and for suppressing transgene expression for a protrated period of time comprising an attenuated strain of bacterial cells which preferentially target phagocytic cells of the intestinal mucosa, and which serve as a vehicle for a plasmid vector carrying one or more genes or complementary DNA coding for at least a portion of a hepatitis B viral protein or peptide. Given orally, the DNA composition causes a transient and self-limiting infection of the intestinal tract through autolysis of the bacterial cells and release of the plasmid after gaining entry into infected host cells.; A promotor contained within the plasmid allows for expression of the HBV genes in the eurokaryotic environment, the viral products of which help to booster a cell-mediated immunity to clear the infection and reverse a state of immune tolerance characteristic of HBV chronic infection.
Persistent Identifierhttp://hdl.handle.net/10722/177064

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:39:01Z-
dc.date.available2012-11-30T08:39:01Z-
dc.date.issued2003-
dc.identifier.citationWO Published patent application WO 03072012. World Intellectual Property Organization (WIPO), PatentScope, 2003en_HK
dc.identifier.urihttp://hdl.handle.net/10722/177064-
dc.description.abstractThe present invention provides an oral DNA composition for improving an impaired immunity associated with chronic infection of hepatitis B virus HBV and for suppressing transgene expression for a protrated period of time comprising an attenuated strain of bacterial cells which preferentially target phagocytic cells of the intestinal mucosa, and which serve as a vehicle for a plasmid vector carrying one or more genes or complementary DNA coding for at least a portion of a hepatitis B viral protein or peptide. Given orally, the DNA composition causes a transient and self-limiting infection of the intestinal tract through autolysis of the bacterial cells and release of the plasmid after gaining entry into infected host cells.; A promotor contained within the plasmid allows for expression of the HBV genes in the eurokaryotic environment, the viral products of which help to booster a cell-mediated immunity to clear the infection and reverse a state of immune tolerance characteristic of HBV chronic infection.en_HK
dc.titleORAL DNA COMPOSITION FOR HEPATITIS B VIRUS CHRONIC INFECTIONen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorNg, Munhonen_HK
dc.contributor.inventorYuen, KYen_HK
dc.contributor.inventorZheng, Ben_HK
patents.identifier.applicationPC T/CN2003000160en_HK
patents.description.assigneeUNIV HONG KONG [CN]en_HK
patents.description.countryWorld Intellectual Property Organization (WIPO)en_HK
patents.date.publication2003-09-04en_HK
patents.date.application2003-02-28en_HK
patents.date.priority2002-02-28 US 10/359945Pen_HK
patents.description.ccWOen_HK
patents.identifier.publicationWO 03072012en_HK
patents.relation.familyAU 2003210122 (A1) 2003-09-09en_HK
patents.relation.familyCA 2380471 (A1) 2003-08-28en_HK
patents.relation.familyCN 1444996 (A) 2003-10-01en_HK
patents.relation.familyCN 100528238 (C) 2009-08-19en_HK
patents.relation.familyHK 1058144 (A1) 2010-04-23en_HK
patents.relation.familyUS 2003162741 (A1) 2003-08-28en_HK
patents.relation.familyUS 2006228374 (A1) 2006-10-12en_HK
patents.relation.familyWO 03072012 (A2) 2003-09-04en_HK
patents.description.kindA2en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats